perflubron has been researched along with Fibrosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barth, ED; Grdina, DJ; Halpern, HJ; Karczmar, GS; Peric, M; River, JN; Teicher, BA; Yu, C | 1 |
| Ara, G; Ha, CS; Herman, TS; Holden, SA; Northey, D; Teicher, BA | 1 |
2 other study(ies) available for perflubron and Fibrosarcoma
| Article | Year |
|---|---|
Measurement of differences in pO2 in response to perfluorocarbon/carbogen in FSa and NFSa murine fibrosarcomas with low-frequency electron paramagnetic resonance oximetry.
Topics: Animals; Breast Neoplasms; Carbon Dioxide; Cell Division; Cell Line; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Female; Fibrosarcoma; Fluorocarbons; Humans; Hydrocarbons, Brominated; Magnetic Resonance Imaging; Mice; Mice, Inbred C3H; Oximetry; Oxygen; Partial Pressure; Radiation-Sensitizing Agents; Spin Labels; Tumor Cells, Cultured | 1996 |
A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.
Topics: Administration, Inhalation; Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Carbon Dioxide; Carmustine; Cell Survival; Cyclophosphamide; Drug Administration Schedule; Drug Synergism; Emulsions; Fibrosarcoma; Fluorocarbons; Hematopoietic Stem Cells; Hydrocarbons, Brominated; Male; Melphalan; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Oxygen; Tumor Cells, Cultured | 1992 |